Fungal Infection
16 drugs5,707 FAERS reportsMedDRA PT
GET
/api/v1/reaction/fungal-infectionReference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.
DefinitionNLM MeSH D009181
Diseases caused by FUNGI.
Drugs reporting Fungal Infection (16)
Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.
- 1Picea Mariana Resin150%
- 2Epstein-barr Virus125%
- 3Butoconazole120%
- 4Oteseconazole27.4%
- 5Asiatic Acid16.7%
- 6Ertugliflozin635.0%
- 7Canagliflozin1,4904.8%
- 8Sotagliflozin173.3%
- 9Empagliflozin2,2463.2%
- 10Terconazole243.0%
- 11Daunorubicin1042.8%
- 12Micafungin2232.7%
- 13Rezafungin22.6%
- 14Sepiapterin12.6%
- 15Caspofungin1182.5%
- 16Dapagliflozin1,4132.5%
Related reactions
Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.
- Diabetic Ketoacidosis4 shared · 0.20
- Ketoacidosis2 shared · 0.13
- Candida Infection3 shared · 0.10
- Bronchopulmonary Aspergillosis2 shared · 0.10
- Cellulitis2 shared · 0.07
- Pregnancy2 shared · 0.07
- Dysuria2 shared · 0.07
- Blood Glucose Increased4 shared · 0.05
- Septic Shock3 shared · 0.05
- Flatulence2 shared · 0.04
Literature
Recent PubMed references pinned to Mycoses as a MeSH major topic. About the reaction term itself — not about any specific drug.
- Histoplasmosis with mediastinal lymphadenopathy in an immunocompetent municipal water department employee in Texas: a case report.Frontiers in cellular and infection microbiology · 2026 · Wang T, Fajkus A, Fairweather M, et al.PMID 42205478DOI 10.3389/fcimb.2026.1808506
- Diagnosis, treatment, and biosafety protection of imported highly pathogenic cutaneous fungal infection: a case-based study of cutaneous coccidioidomycosis.Frontiers in public health · 2026 · Weng Y, Liu Z, Xia X, et al.PMID 42205442DOI 10.3389/fpubh.2026.1833316
- Evolving Epidemiology and Emerging Antifungal Resistance in Vulvovaginal Candidosis: Evidence from a Five-Year Survey.Pathogens (Basel, Switzerland) · 2026 · Tsiakalos A, Papageorgiou D, Pitiriga VC, et al.PMID 42198664DOI 10.3390/pathogens15050538
- Past Achievements, Present Gaps, and Future Priorities in Pneumocystis jirovecii Research: A Global Bibliometric Analysis.Pathogens (Basel, Switzerland) · 2026 · Ortiz B, Muñoz-Tabora J, Aguilar K, et al.PMID 42198656DOI 10.3390/pathogens15050530
- Curvularia spicifera in Non-Invasive Fungal Rhinosinusitis: Case Reports and Diagnostic Insights.Pathogens (Basel, Switzerland) · 2026 · Ferraro N, Iskandar E, Pitrolo AMG, et al.PMID 42198649DOI 10.3390/pathogens15050523
- Molecular Mechanisms of Mucormycosis Pathogenesis: Host-Pathogen Interactions and Immune Evasion.Pathogens (Basel, Switzerland) · 2026 · Alanazi A, Ibrahim MN, Alenezi MA, et al.PMID 42198648DOI 10.3390/pathogens15050522
Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.